DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/nx6xdp/_water_for) has announced the addition of the "Water for Pharmaceuticals: Opportunities in the developed and emerging markets" report to their offering.
The pharmaceutical industry is suffering a period of uncertainty in the wake of the patent cliff in 2011. The days of double digit growth for Big Pharma are over as several blockbuster drugs expire simultaneously, so pharmaceutical companies have been rethinking their business models to counter losses and are turning to market consolidation to maintain their revenues and profits.
What does this mean for the water sector?
Water is a critical element of the pharmaceutical business and these changes will ultimately have a knock-on effect for water companies working within the sector. Cost reduction is the overriding priority for the pharmaceuticals industry - facilities are being closed or downsized and procurement managers are opting for low cost systems over high quality. It is essential that water companies understand these developments and plan for the future to overcome margin erosion, remain competitive and to win bids.
Water companies need a sharp eye on emerging opportunities and an adequate understanding of the changes in the industry to maintain success in this changing market. This new GWI Analysts' Report - Water for Pharmaceuticals - is a crucial tool for any water company working within the pharmaceuticals market. Offering you all the intelligence you need in around 50 pages, we help you minimise the impact of these changes on your business and show you the regions and trends still creating opportunities for your solutions - so you can build a robust strategy for the future and maintain your bottom line during this time of flux.
Key Topics Covered:
1. Market overview
2. Global outlook
3. Technology trends
4. Competitive dynamic
For more information visit http://www.researchandmarkets.com/research/nx6xdp/_water_for